feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Tingling Arm: A Deadly Glioblastoma Warning

Tingling Arm: A Deadly Glioblastoma Warning

8 Jan

•

Summary

  • A tingling arm symptom preceded a glioblastoma diagnosis in a 38-year-old man.
  • He faces a prognosis of 12 to 18 months with an aggressive brain tumor.
  • Limited treatment access in the UK prompts patients to seek costly overseas options.
Tingling Arm: A Deadly Glioblastoma Warning

A man's life was irrevocably altered when a tingling sensation in his arm signaled an aggressive brain tumor. Matt Collins, 38, experienced a sudden loss of function in his left arm, leading to his diagnosis of glioblastoma, the most aggressive form of brain cancer. Doctors delivered a grim prognosis of 12 to 18 months, a reality that profoundly impacted Collins and his family.

Following successful surgery in 2023 to remove the golf ball-sized tumor, it recurred, and subsequent chemotherapy proved ineffective. This setback underscores the severe limitations in treatment options for brain tumors in the UK, which are the leading cause of cancer death in children and individuals under 40. Many patients, like Collins, must increasingly seek expensive treatments abroad.

Collins's case highlights the disparity in research funding and treatment accessibility. He received a bespoke vaccine, DcVax-L, thanks to public donations, costing £100,000. He now eyes a German therapy at £16,000 per cycle, questioning why such treatments aren't more accessible through the NHS, a sentiment echoed by research charities advocating for increased investment and better patient sample handling.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Matt Collins experienced a tingling sensation in his arm, which later led to a sudden loss of function.
Glioblastoma is the most aggressive type of brain tumor, with Matt Collins given a prognosis of 12 to 18 months.
Access to cutting-edge immunotherapies and specialist drug trials is scarce in the UK, forcing patients to fund private or overseas care.

Read more news on

Healthside-arrow
trending

Daycare workers sentenced for abuse

trending

USS Abraham Lincoln drills China

trending

Patriots await Steelers or Texans

trending

Astronauts return after health crisis

trending

Bills Broncos NFL Playoff Game

trending

Sakkari faces Kasatkina Adelaide

trending

Chalamet wins Golden Globe

trending

Jaqueline Cristian qualifies Adelaide draw

trending

Amen Thompson scores 31 points

You may also like

TSMC Surges to Record Profit on AI Chip Demand

7 hours ago • 27 reads

article image

Trump's Rate Cap Plan Shakes Financial Stocks

1 hour ago • 4 reads

article image

Abivax Soars on Eli Lilly Acquisition Rumors

1 hour ago • 5 reads

article image

Niners vs. Seahawks: Ultimate Rivalry Rematch

1 hour ago • 4 reads

article image

Body Broker Scandal: Dad's Remains Sold After Donation

1 hour ago • 8 reads

article image